Corticobasal DegenerationSymptoms, Doctors, Treatments, Advances & More
Corticobasal Degeneration Overview
Learn About Corticobasal Degeneration
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Memory And Aging Center
Adam Boxer is a Neurologist practicing medicine in San Francisco, California. Dr. Boxer is rated as an Elite provider by MediFind in the treatment of Corticobasal Degeneration. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Corticobasal Degeneration. Dr. Boxer is board certified in American Board Of Psychiatry/Neurology-Psychiatry, Neurology. Dr. Boxer is currently accepting new patients.
Memory And Aging Center
William Seeley is a Neurologist practicing medicine in San Francisco, California. Dr. Seeley is rated as an Elite provider by MediFind in the treatment of Corticobasal Degeneration. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Frontotemporal Dementia, Dementia, Primary Progressive Aphasia, and Alzheimer's Disease. Dr. Seeley is board certified in American Board Of Psychiatry And Neurology., Neurology. Dr. Seeley is currently accepting new patients.
Memory And Aging Center
Salvatore Spina is a Neurologist practicing medicine in San Francisco, California. Dr. Spina is rated as an Elite provider by MediFind in the treatment of Corticobasal Degeneration. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Dementia, Corticobasal Degeneration, Alzheimer's Disease, and Frontotemporal Dementia. Dr. Spina is board certified in American Board Of Psychiatry And Neurology., Neurology. Dr. Spina is currently accepting new patients.
Summary: This goal of this observational study is to clarify the variations in the natural course of atypical parkinsonian syndromes (APS, including MSA, DLB, PSP, and CBD), such as the progression rate of motor and non-motor symptoms and characteristic imaging evolution patterns. Establish a comprehensive assessment framework for APS, and develop clinical and biological databases to identify biomarkers wi...
Summary: MARKERS-NDD is a prospective, observational, longitudinal study, which aims to collect data from patients affected by neurodegenerative diseases (NDD) followed longitudinally for routine examinations performed as part of normal clinical practice. Data collected from clinical evaluations, movement analysis, brain imaging, neuropsychological and electroencephalographic assessments, blood chemistry t...


